You can find the annual or quarterly income statement of aTyr Pharma Ord Shs here for insights into the performance and operational efficiency of aTyr Pharma Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Total revenue

--190.00K

Revenue

--190.00K

Operating expenses

--26.93M

R&D expenses

--22.13M

Depreciation, depletion, and amortization

--165.00K

Operating profit

---26.75M

Net non-operating interest income (expenses)

Other non-operating income (expenses)

--999.00K

Income before tax

---25.75M

Income after tax

---25.75M

Net income from continuous operations

---25.75M

Net Income attributable to non-controlling interests

---2.00K

Net income attributable to controlling interests

---25.74M

Net income attributable to common shareholders

---25.74M

Basic earnings per share

---0.26

Diluted earnings per share

---0.26

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

